These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27321390)

  • 1. Novel function of histamine signaling via histamine receptors in cholesterol and bile acid metabolism: Histamine H2 receptor protects against nonalcoholic fatty liver disease.
    Yamada S; Guo X; Wang KY; Tanimoto A; Sasaguri Y
    Pathol Int; 2016 Jul; 66(7):376-85. PubMed ID: 27321390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
    Rao A; Kosters A; Mells JE; Zhang W; Setchell KD; Amanso AM; Wynn GM; Xu T; Keller BT; Yin H; Banton S; Jones DP; Wu H; Dawson PA; Karpen SJ
    Sci Transl Med; 2016 Sep; 8(357):357ra122. PubMed ID: 27655848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine regulation in glucose and lipid metabolism via histamine receptors: model for nonalcoholic steatohepatitis in mice.
    Wang KY; Tanimoto A; Yamada S; Guo X; Ding Y; Watanabe T; Watanabe T; Kohno K; Hirano K; Tsukada H; Sasaguri Y
    Am J Pathol; 2010 Aug; 177(2):713-23. PubMed ID: 20566747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease.
    Tan X; Liu Y; Long J; Chen S; Liao G; Wu S; Li C; Wang L; Ling W; Zhu H
    Mol Nutr Food Res; 2019 Sep; 63(17):e1900257. PubMed ID: 31095863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles of histamine H1- and H2-receptor signaling pathways in inflammation-associated colonic tumorigenesis.
    Shi Z; Fultz RS; Engevik MA; Gao C; Hall A; Major A; Mori-Akiyama Y; Versalovic J
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G205-G216. PubMed ID: 30462522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Mechanism of Common Buckwheat (
    Huang ZR; Deng JC; Li QY; Cao YJ; Lin YC; Bai WD; Liu B; Rao PF; Ni L; Lv XC
    J Agric Food Chem; 2020 Jun; 68(24):6530-6543. PubMed ID: 32383865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel function of histamine signaling in hyperlipidemia-induced atherosclerosis: Histamine H1 receptors protect and H2 receptors accelerate atherosclerosis.
    Yamada S; Wang KY; Tanimoto A; Sasaguri Y
    Pathol Int; 2015 Feb; 65(2):67-80. PubMed ID: 25581821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pectin Penta-Oligogalacturonide Suppresses Intestinal Bile Acids Absorption and Downregulates the FXR-FGF15 Axis in High-Cholesterol Fed Mice.
    Zhu R; Hou Y; Sun Y; Li T; Fan J; Chen G; Wei J
    Lipids; 2017 Jun; 52(6):489-498. PubMed ID: 28474246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaphylactic responses to histamine in mice utilize both histamine receptors 1 and 2.
    Wechsler JB; Schroeder HA; Byrne AJ; Chien KB; Bryce PJ
    Allergy; 2013 Oct; 68(10):1338-40. PubMed ID: 24112077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice.
    Chevre R; Trigueros-Motos L; Castaño D; Chua T; Corlianò M; Patankar JV; Sng L; Sim L; Juin TL; Carissimo G; Ng LFP; Yi CNJ; Eliathamby CC; Groen AK; Hayden MR; Singaraja RR
    FASEB J; 2018 Jul; 32(7):3792-3802. PubMed ID: 29481310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholic acid supplementation accelerates the progression of nonalcoholic fatty liver disease to the procarcinogenic state in mice fed a high-fat and high-cholesterol diet.
    Chun HJ; Shim YJ; Kwon YH
    J Nutr Biochem; 2022 Feb; 100():108869. PubMed ID: 34563665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sortilin 1 Loss-of-Function Protects Against Cholestatic Liver Injury by Attenuating Hepatic Bile Acid Accumulation in Bile Duct Ligated Mice.
    Li J; Woolbright BL; Zhao W; Wang Y; Matye D; Hagenbuch B; Jaeschke H; Li T
    Toxicol Sci; 2018 Jan; 161(1):34-47. PubMed ID: 28453831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical in vivo roles of histamine and histamine receptor signaling in animal models of metabolic syndrome.
    Yamada S; Tanimoto A; Sasaguri Y
    Pathol Int; 2016 Dec; 66(12):661-671. PubMed ID: 27860077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice.
    Péan N; Doignon I; Garcin I; Besnard A; Julien B; Liu B; Branchereau S; Spraul A; Guettier C; Humbert L; Schoonjans K; Rainteau D; Tordjmann T
    Hepatology; 2013 Oct; 58(4):1451-60. PubMed ID: 23686672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol feeding prevents hepatic accumulation of bile acids in cholic acid-fed farnesoid X receptor (FXR)-null mice: FXR-independent suppression of intestinal bile acid absorption.
    Miyata M; Matsuda Y; Nomoto M; Takamatsu Y; Sato N; Hamatsu M; Dawson PA; Gonzalez FJ; Yamazoe Y
    Drug Metab Dispos; 2009 Feb; 37(2):338-44. PubMed ID: 18988759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary Isoquercetin Reduces Hepatic Cholesterol and Triglyceride in NAFLD Mice by Modulating Bile Acid Metabolism via Intestinal FXR-FGF15 Signaling.
    Zhang C; Shi Z; Lei H; Wu F; Chen C; Cao Z; Song Y; Zhang C; Zhou J; Lu Y; Zhang L
    J Agric Food Chem; 2023 May; 71(20):7723-7733. PubMed ID: 37166409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perilla Oil Supplementation Ameliorates High-Fat/High-Cholesterol Diet Induced Nonalcoholic Fatty Liver Disease in Rats via Enhanced Fecal Cholesterol and Bile Acid Excretion.
    Chen T; Yuan F; Wang H; Tian Y; He L; Shao Y; Li N; Liu Z
    Biomed Res Int; 2016; 2016():2384561. PubMed ID: 27642591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cholesterol, cholic acid and cholestyramine administration on the intestinal mRNA expressions related to cholesterol and bile acid metabolism in the rat.
    Kamisako T; Ogawa H; Yamamoto K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1832-7. PubMed ID: 17498222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.
    Bechmann LP; Kocabayoglu P; Sowa JP; Sydor S; Best J; Schlattjan M; Beilfuss A; Schmitt J; Hannivoort RA; Kilicarslan A; Rust C; Berr F; Tschopp O; Gerken G; Friedman SL; Geier A; Canbay A
    Hepatology; 2013 Apr; 57(4):1394-406. PubMed ID: 23299969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
    Mouzaki M; Wang AY; Bandsma R; Comelli EM; Arendt BM; Zhang L; Fung S; Fischer SE; McGilvray IG; Allard JP
    PLoS One; 2016; 11(5):e0151829. PubMed ID: 27203081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.